Q3 FY2026 · Interim report
Read Novo Nordisk A/S Class B's results firsthand
Preview the first 2 pages of this interim report
Create a free account to start reading
Full documents are included with Professional
Novo Nordisk A/S Class B
40.19
USD
-0.26
(-0.64%)
